Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Premiums	$ 122,896	$ 99,192	$ 85,330
Net investment income	2,153	1,153	838
Total revenues	372,809	357,776	322,467
Operating costs:
Cost of products sold	206,287	217,098	196,892
Health care costs	115,121	86,247	71,073
Operating expenses	41,606	39,832	38,212
Restructuring charges	1,179	507	0
Opioid litigation charges	100	0	5,803
Loss on assets held for sale	0	349	2,533
Total operating costs	364,293	344,033	314,513
Operating income	8,516	13,743	7,954
Interest expense	2,958	2,658	2,287
Gain on early extinguishment of debt	(491)	0	0
Other income	(99)	(88)	(169)
Income before income tax provision	6,148	11,173	5,836
Income tax provision	1,562	2,805	1,509
Net income	4,586	8,368	4,327
Net (income) loss attributable to noncontrolling interests	28	(24)	(16)
Net income attributable to CVS Health	$ 4,614	$ 8,344	$ 4,311
Net income per share attributable to CVS Health:
Basic (in dollars per share)	$ 3.67	$ 6.49	$ 3.29
Diluted (in dollars per share)	$ 3.66	$ 6.47	$ 3.26
Weighted average shares outstanding:
Basic (in shares)	1,259	1,285	1,312
Diluted (in shares)	1,262	1,290	1,323
Cost, Product and Service [Extensible List]	Products	Products	Products
Products
Revenues:
Revenues	$ 231,521	$ 245,138	$ 226,616
Services
Revenues:
Revenues	$ 16,239	$ 12,293	$ 9,683